SCHEMBL8552055

SCHEMBL8552055

NC(=O)CN1CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piracetam SCHEMBL20172 0.87 TSHR (1.00)
Piracetam SCHEMBL6140872 0.87 TSHR (1.00)
SCHEMBL24263535 0.85 TSHR (0.89)
Piracetam SCHEMBL28423013 0.85 TSHR (0.96)
SCHEMBL1532937 0.84 TSHR (0.85)
SCHEMBL13315045 0.80 TSHR (0.57)
SCHEMBL6361223 0.79 TSHR (0.50)
SCHEMBL43400 0.79
SCHEMBL11315834 0.77
SCHEMBL7771566 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0840725-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-05-13 EP disclosed
EP-0799200-A1 SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-10-08 EP disclosed
WO-1997002242-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-01-23 WO disclosed
EP-0171159-B1 SUBSTITUTED AZETIDINONE COMPOUNDS, THEIR PREPARATION, AND MEDICAMENTS CONTAINING THEM YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1990-05-30 EP disclosed
US-4719207-A CENTRAL NERVOUS SYSTEM YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1988-01-12 US disclosed
EP-0171159-A1 Substituted azetidinone compounds, their preparation, and medicaments containing them YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1986-02-12 EP disclosed